newsfilter
← Latest News
GlobeNewswire·

VYNE Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference

BRIDGEWATER, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company"), a clinical-stage biopharmaceutical company developing proprietary, innovative, and differentiated